Jean Lehmann

Jean Lehmann

Direktor/Vorstandsmitglied bei CALYXT, INC.

Vermögen: 26 Mio $ am 30.04.2024

85 Jahre
Health Technology
Consumer Services
Finance

Ursprung des Netzwerks ersten Grades von Jean Lehmann

EinheitArt der EinheitIndustrie
Holding Company Biotechnology 16
11
Subsidiary Biotechnology 11
10
Subsidiary Biotechnology 10
Public Company Information Technology Services 8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Jean Lehmann

UnternehmenSektorVerknüpfte PersonenHauptposition
CARDINAL HEALTH, INC. Medical Distributors

Jonathan Wygant

Jim Hinrichs

Corporate Officer/Principal

Director of Finance/CFO

ALERE INC Medical Specialties

Jonathan Wygant

Jim Hinrichs

Director of Finance/CFO

Director of Finance/CFO

INTERPACE BIOSCIENCES, INC. Medical Specialties

Harry Glorikian

Corporate Officer/Principal

CEPHEID Medical Specialties

Harry Glorikian

Consultant / Advisor

Investment Managers

Rory Riggs

Mark Finn

Corporate Officer/Principal

Corporate Officer/Principal

CAREFUSION CORPORATION Medical Distributors

Jonathan Wygant

Jim Hinrichs

Comptroller/Controller/Auditor

Director of Finance/CFO

Medical/Nursing Services

Harry Glorikian

Consultant / Advisor

Major Banks

Mark Finn

Mark Finn

Corporate Officer/Principal

Chief Investment Officer

Boston University College/University

Harry Glorikian

Masters Business Admin

Internet Software/Services

Chang Keng Lo

Director/Board Member

FIBROGEN, INC. Pharmaceuticals: Major

Rory Riggs

Stephen Evans-Freke

Founder

Founder

Yale University College/University

Eugene Linden

Keith Walker

Undergraduate Degree

Doctorate Degree

San Francisco State University College/University

Harry Glorikian

Undergraduate Degree

Simon Fraser University College/University

Chang Keng Lo

Mark Lu

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Keith Walker

Peter Beetham

David A. Voss

Greg Gocal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Hospital/Nursing Management

Harry Glorikian

Consultant / Advisor

STAGEZERO LIFE SCIENCES LTD. Medical Specialties

Rory Riggs

Harry Glorikian

Founder

Director/Board Member

Other Consumer Services

Rory Riggs

Mark Finn

Chief Executive Officer

Director/Board Member

Investment Managers

Stephen Evans-Freke

Mark Finn

Founder

Consultant / Advisor

Food Retail

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Kunshan Rotam Reddy Pharmaceutical Co., Ltd.

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

ROTAM GLOBAL AGROSCIENCES LIMITED Chemicals: Agricultural

Chang Keng Lo

Mark Lu

Founder

Founder

Chemicals: Agricultural

Chang Keng Lo

Director/Board Member

Rotam Investments Ltd.

Chang Keng Lo

Director/Board Member

Rotam Chemia Technology (HK) Ltd.

Chang Keng Lo

Director/Board Member

Triumph Year International Ltd.

Chang Keng Lo

Director/Board Member

Rotam Veterinary Co., Ltd.

Chang Keng Lo

Director/Board Member

Double Glory Holdings Ltd.

Chang Keng Lo

Director/Board Member

Witgang Far East Ltd.

Chang Keng Lo

Director/Board Member

Chemicals: Agricultural

Chang Keng Lo

Director/Board Member

Rotam India Ltd.

Chang Keng Lo

Director/Board Member

Wholesale Distributors

Chang Keng Lo

Director/Board Member

New Skyland International Ltd.

Chang Keng Lo

Director/Board Member

Crop Solutions Ltd.

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Financial Conglomerates

Chang Keng Lo

Director/Board Member

Number Success Ltd.

Chang Keng Lo

Director/Board Member

Containers/Packaging

Chang Keng Lo

Mark Lu

Chairman

Chairman

Amaethon-Environmental Ltd.

Chang Keng Lo

Director/Board Member

Rotam Chemical Co. Ltd.

Chang Keng Lo

Director/Board Member

Canada Rotam Group Ltd.

Chang Keng Lo

Director/Board Member

X-Cell Laboratories

Harry Glorikian

Founder

Investment Managers

Rory Riggs

Harry Glorikian

Mark Finn

Founder

Private Equity Investor

Private Equity Investor

Pharmaceuticals: Major

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Chong Dah Pharmaceutical Co., Ltd.

Chang Keng Lo

Mark Lu

Director/Board Member

Director/Board Member

Statistik

International

Vereinigte Staaten 20
Hong Kong 11
Taiwan 7
Kanada 5
China 3

Sektoral

Finance 9
Health Technology 8
Process Industries 6
Consumer Services 6
Distribution Services 4

Operativ

Director/Board Member 160
Corporate Officer/Principal 58
Founder 35
Chairman 34
President 22
  1. Börse
  2. Insiders
  3. Jean Lehmann
  4. Unternehmensverbindungen